MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1

被引:19
|
作者
Ding, X. [1 ]
Yang, Y. [2 ]
Sun, Y. [3 ]
Xu, W. [1 ]
Su, B. [1 ]
Zhou, X. [3 ]
机构
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Cent Lab, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2017年 / 19卷 / 05期
关键词
miR-585; Non-small-cell lung cancer; Proliferation; Invasion; hSMG-1; HUMAN SMG-1; KINASE; GENOME; ATM;
D O I
10.1007/s12094-016-1562-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the role of miR-585 in the development and progression of non-small-cell lung cancer (NSCLC). The expression levels of miR-585 in NSCLC cell lines and clinical samples were measured by quantitative PCR. NSCLC cells, A549 and H1299, were stably transfected with lentiviral vectors of miR-585 mimics or negative control. The effects of miR-585 on cell proliferation were detected both in vitro and in vivo. Cell migration and invasion were evaluated using wound healing assay and Transwell assay. Furthermore, luciferase reporter assay was used to identify the direct regulation of hSMG-1 by miR-585. Our results showed that miR-585 was downregulated in NSCLC cell lines and tumor tissues. Ectopic expression of miR-585 inhibited the ability of cell proliferation, migration, and invasion in vitro. In addition, miR-585 also decreased the growth rate of xenografted tumor in nude mice. Mechanically, miR-585 directly targeted the 3'-untranslated region (UTR) of hSMG-1 gene, which likely resulted in a dysfunction of mRNA surveillance and nonsense-mediated mRNA decay. Taken together, miR-585 probably has an inhibitory effect on tumor growth and is a prognostic biomarker of NSCLC.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 50 条
  • [21] MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1
    Xia, L-H
    Yan, Q-H
    Sun, O-D
    Gao, Y-P
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (17) : 5546 - 5553
  • [22] Targeting PD-L1 for non-small-cell lung cancer
    Feld, Emily
    Horn, Leora
    IMMUNOTHERAPY, 2016, 8 (06) : 747 - 758
  • [23] Targeting the eicosanoid pathway in non-small-cell lung cancer
    Horn, Leora
    Backlund, Michael
    Johnson, David H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (06) : 675 - 688
  • [24] Targeting DNA methyltransferases in non-small-cell lung cancer
    Al-Yozbaki, Minnatallah
    Jabre, Ibtissam
    Syed, Naeem H.
    Wilson, Cornelia M.
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 77 - 87
  • [25] Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Kasahara, Norimitsu
    Sakurai, Reiko
    CANCERS, 2021, 13 (23)
  • [26] MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2
    Huang, Ping
    Ye, Bo
    Yang, Yu
    Shi, Jianxin
    Zhao, Heng
    TUMOR BIOLOGY, 2015, 36 (05) : 3381 - 3387
  • [27] MicroRNA-625 serves as a tumor suppressor in non-small cell lung cancer through targeting SOX4
    Li, Jun-Ying
    Liang, Zong-An
    Zheng, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3225 - 3234
  • [28] MicroRNA-28 promotes the proliferation of non-small-cell lung cancer cells by targeting PTEN
    Cui, Fenghe
    Zhou, Qian
    Xiao, Kuang
    Qian, Haiyun
    MOLECULAR MEDICINE REPORTS, 2020, 21 (06) : 2589 - 2596
  • [29] Epigenetic and genetic inactivation of tumor suppressor miR-135a in non-small-cell lung cancer
    Choi, Jin Eun
    Jeon, Hyo Sung
    Wee, Hyun Jung
    Lee, Ji Yun
    Lee, Won Kee
    Lee, Shin Yup
    Yoo, Seung Soo
    Choi, Sun Ha
    Kim, Dong Sun
    Park, Jae Yong
    THORACIC CANCER, 2023, 14 (11) : 1012 - 1020
  • [30] Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer
    Cascone, Tina
    Fradette, Jared
    Pradhan, Monika
    Gibbons, Don L.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2022, 12 (05):